Mobileye NV (NYSE:MBLY) shares are soaring by 29% on Monday morning following the announcement that computer-chip giant Intel is acquiring Mobileye for …
Heat Biologics Inc (NASDAQ:HTBX) shares fell over 65% this month, after the firm’s Phase II data read-out from its HS-410 bladder cancer trial …
The biotech-verse is in full upheaval mode as Heat Biologics Inc (NASDAQ:HTBX) shares nosedive following disheartening Phase II results in bladder cancer and …
Today, Heat Biologics Inc (NASDAQ:HTBX) presented randomized Phase II data from the HS-410 bladder cancer study. The primary endpoint of the study, one …
Heat Biologics Inc (NASDAQ:HTBX) announced that the company has resumed enrollment in its Phase 1b trial evaluating HS-110 in combination with nivolumab (Opdivo®), …
